Meeting
2016 ASCO Annual Meeting
Association of FBXW7 missense mutations (mt) with unfavorable prognosis in metastatic colorectal cancer (mCRC) patients (pts).
Authors
Krittiya Korphaisarn
The University of Texas MD Anderson Cancer Center, Houston, TX
Krittiya Korphaisarn , Michael J. Overman , David R. Fogelman , Bryan K. Kee , Kanwal Pratap Singh Raghav , Imad Shureiqui , Robert A. Wolff , Keyur Patel , Kenna Rael Shaw , Cathy Eng , Dipen M. Maru , Mark Routbort , Funda Meric-Bernstam , Scott Kopetz , Van Karlyle Morris II, Eduardo Vilar-Sanchez , Shanequa Manuel , A. Dasari
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Epidemiology/Outcomes
Citation
J Clin Oncol 34, 2016 (suppl; abstr 3607)
DOI
10.1200/JCO.2016.34.15_suppl.3607
Abstract #
3607
Poster Bd #
304
Abstract Disclosures
Similar Posters
Poster
2013 ASCO Annual Meeting
Massively parallel sequencing (MPS) of circulating DNA in patients with metastatic colorectal cancer (mCRC): Prognostic significance and early changes during chemotherapy (CT).
First Author: Jeanne Tie
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Association of candidate alterations with primary resistance to KRAS G12D targeting in colorectal cancer.
First Author: Khalid Jazieh
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Tumor genomics and sidedness to predict outcomes in metastatic colorectal cancer (mCRC).
First Author: Patrick M Boland
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Real-world clinicopathological and molecular characteristics, treatment patterns, and outcomes in patients with KRAS G12C–mutated metastatic colorectal cancer in AACR Project GENIE.
First Author: Hil Hsu